Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582491 · ClinicalTrials.gov registry record · NA
Modafinil, Sleep, and Cognition in Cocaine Dependence
A NA study of Cocaine Dependence and Substance-induced Sleep Disorder, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT00582491 is a NA study of Cocaine Dependence and Substance-induced Sleep Disorder that has completed, run by Yale University. The registered enrollment target is 44 participants, below the 297-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00582491, a NA study of Cocaine Dependence and Substance-induced Sleep Disorder, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects participating in this protocol will participate in three phases: 1) pre-admission, 2) inpatient admission, and 3) follow-up. Pre-admission involves screening (detailed in inclusion/exclusion criteria section) and one week of outpatient sleep and activity monitoring. Inpatient admission is 16 consecutive nights on the Clinical Neuroscience Research Unit and involves subjective and objective tests of sleep, sleepiness, attention, and learning. During inpatient admission subjects will take modafinil or placebo. For follow-up, subjects will return to the CNRU for one night and again participate in objective tests of sleep, sleepiness, attention, and learning. We hypothesize that modafinil will decrease subject and objective measures of sleepiness and will promote attention and learning in cocaine dependent persons.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Modafinil
Study Locations (1)
Connecticut
- Connecticut Mental Health Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582491
The ClinicalTrials.gov registry entry for NCT00582491 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 297-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (85% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cocaine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00582491 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00582491 about?
NCT00582491 is a clinical study titled "Modafinil, Sleep, and Cognition in Cocaine Dependence". Subjects participating in this protocol will participate in three phases: 1) pre-admission, 2) inpatient admission, and 3) follow-up. Pre-admission involves screening (detailed in inclusion/exclusion criteria section) and one week of outpatient sleep and activity monitoring. Inpatient admission is 1...
What is the current status of trial NCT00582491?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2006-08. Estimated completion is 2009-02.
What conditions does trial NCT00582491 study?
This clinical trial studies the following conditions: Cocaine Dependence, Substance-induced Sleep Disorder, Substance-induced Cognitive Disorder.
What interventions are being tested in trial NCT00582491?
The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG).
Who is sponsoring clinical trial NCT00582491?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582491 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
RECRUITING · NA
-
Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2
COMPLETED · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
-
Exercise as a Behavioral Treatment for Cocaine Dependence
COMPLETED · NA
-
Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET
COMPLETED · NA
-
Effectiveness of Extended Treatments for Drug Dependence
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.